Dishman Opens Dishman Netherlands, cGMP Laboratory

Dishman Netherlands has oppened its containment cGMP laboratory on November 27, 2009. It was inaugrated by Jay Vyas, chairman and owner of the Indian Dishman Group. Important attendees included different representatives from Pfizer and Solvay.

Reportedly, the project was realised with the support of several companies: Van Spanje, Techtron, Cleangrad, de Van Looy Group, Termovent and Waldner Benelux.

Dishman Netherlands has accomplished the construction and validation of a full cGMP production laboratory for APIs in Veenendaal, The Netherlands. The laboratory consists of 6 dedicated clean rooms with a scale of operation of up to 1kg in addition to all standard laboratory facilities. FDA compliance audit is expected in H1 of 2010.

The company said that the decision to build the production laboratory is part of Dishman’s strategy to develop new Vitamin D analogues and highly potent API’s to complement the current product portfolio. Furthermore, to develop business opportunities with new business partners: for contract research, product development and contract manufacturing.

Dishman Netherlands currently offers vitamin D analogues such as alfacalcidol, calcifediol, calcitriol, & dihydrotachysterol-2. Other products include Vitamin D3 and D2; cholesterol and lanolin alcohols. Vitamin D and vitamin D analogs are used in the food, feed and pharmaceuticals industries.